Full-Time

Financial Accountant

Confirmed live in the last 24 hours

ZOLL Medical Corporation

ZOLL Medical Corporation

1,001-5,000 employees

Develops medical devices for emergency care

No salary listed

Mid

No H1B Sponsorship

Sydney NSW, Australia

Candidate must have the right to work in Australia.

Category
Bookkeeping
Financial Accounting
Financial Analysis
Accounting
Required Skills
Quickbooks
Oracle
Excel/Numbers/Sheets
Requirements
  • Degree in accounting and CPA/CA preferred but not essential.
  • Minimum of 3 years in a similar role
  • Experience in Oracle/Quick books/Reckon/Hyperion or other ERP system
  • Strong excel skills and good working knowledge of other Microsoft office suite applications and MS Teams
  • Have exposure to processes, procedures and compliance
  • Excellent written and communication skills
  • Exceptional attention to detail, organisational skills and can do attitude
  • Team player
Responsibilities
  • Process customer invoices and collections.
  • Review and process supplier invoices and employee reimbursements.
  • Process and manage credit card reconciliation.
  • Assist with the related parties' journals and transaction recording.
  • Perform bank reconciliation
  • Perform balance sheet reconciliations and maintain accurate ledgers.
  • Prepare and lodge company's monthly Business Activity Statements (BAS)
  • Perform and manage monthly & quarterly general ledger closing procedures.
  • Support and assist with additional projects and / or ad-hoc tasks as required.
  • Ensure compliance to ZOLL policies and procedures
Desired Qualifications
  • Relevant experience of a minimum of 3 years in general accounting and reporting
  • Has the right to work in Australia
ZOLL Medical Corporation

ZOLL Medical Corporation

View

ZOLL Medical Corporation develops and sells medical devices and software aimed at improving emergency care and saving lives. Their products include defibrillators, monitoring systems, tools for circulation and CPR feedback, data management solutions, therapeutic temperature management devices, and ventilation equipment. These technologies assist healthcare professionals, emergency medical services (EMS), fire personnel, and even bystanders in providing effective treatment for individuals in need of resuscitation and critical care. ZOLL stands out from its competitors by offering a comprehensive range of products that enhance both clinical outcomes and operational efficiency in emergency situations. The company's goal is to advance the quality of emergency medical care and ensure that more lives are saved during critical moments.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$2.2B

Headquarters

null

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Wearable medical technology complements ZOLL's existing product lines.
  • AI integration in billing enhances ZOLL's AR Boost capabilities.
  • Remote patient monitoring demand aligns with ZOLL's innovative devices.

What critics are saying

  • Increased competition from AI-driven medical device companies.
  • Ongoing legal battle over ransomware attack may cause reputational damage.
  • Rapid tech advancements require continuous R&D investment, straining resources.

What makes ZOLL Medical Corporation unique

  • ZOLL's AutoPulse NXT is developed with direct feedback from Air Methods.
  • ZOLL AR Boost is ranked #1 in 2024 Insurance Discovery Solutions.
  • Therox SSO2 Therapy received an Innovative Technology contract from Vizient.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Casual Work Environment

Company News

Air Methods
May 1st, 2025
Air Methods Enhances Patient Care and Safety with Nationwide Deployment of Zoll(R) AutoPulse(R) NXT

Air Methods collaborated closely with ZOLL to provide direct feedback during the development of the AutoPulse NXT, which was released in 2024.

ZOLL Data
Aug 6th, 2024
Black Book Research Ranks ZOLL(R) AR Boost(R) as the #1 2024 Insurance Discovery Solution

The ZOLL AR Boost(R) Insurance Discovery tool secured the #1 spot in the 2024 Insurance Discovery Solutions category.

Law360
Apr 12th, 2024
Zoll Says 'Cookie-Cutter' Hack Claims Don't Show Harm

Zoll Medical Corp. is asking a Boston federal judge to toss a proposed class action brought by medical device customers whose personal information was released during a ransomware attack last year...

Business Wire
Apr 2nd, 2024
Zoll Receives Innovative Technology Contract From Vizient For Therox Supersaturated Oxygen (Sso2) Therapy

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on the recommendation of hospital experts who serve on one of Vizient’s customer-led councils, and it signifies unique qualities that potentially bring improvement to patient cardiovascular care. Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program. Vizient customer-led councils identify technologies that have the potential to enhance clinical care, patient safety, healthcare worker safety, or improve business operations of healthcare organizations. “Each year, more than 258,000 patients in the U.S. access emergency rooms as a result of heart attacks,1” said Matt Rochner, TherOx General Manager

Business Wire
Feb 13th, 2024
Zoll Jednym Z Pierwszych Producentów Aed Certyfikowanych Zgodnie Z Unijnym Rozporządzeniem W Sprawie Wyrobów Medycznych

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, spółka z Grupy Asahi Kasei produkująca wyroby medyczne i powiązane oprogramowanie, ogłosiła dzisiaj, że defibrylator ZOLL AED 3® został zatwierdzony zgodnie z unijnym rozporządzeniem (UE) 2017/745 w sprawie wyrobów medycznych, zwanym w skrócie „EU MDR”. EU MDR to wprowadzone przez Unię Europejską rozporządzenie 2017/745 w sprawie wyrobów medycznych przyjęte przez Parlament Europejski i Radę w 2017 r. Celem EU MDR jest zagwarantowanie wysokich standardów bezpieczeństwa i jakości wyrobów medycznych wytwarzanych w państwach członkowskich Unii Europejskiej lub dostarczanych na ich terytorium. Firma ZOLL uzyskała właśnie oznakowanie CE swojego defibrylatora ZOLL AED 3 zgodnie z przepisami EU MDR